CUAMC
LXEO icon

China Universal Asset Management Company’s Lexeo Therapeutics LXEO Stock Holding History

China Universal Asset Management Company’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$74.3K Buy
12,952
+1,059
+9% +$7.5K 0.01% 432
2025
Q4 		$118K Buy
11,893
+2,427
+26% +$22.1K 0.01% 399
2025
Q3 		$62.9K Buy
9,466
+2,799
+42% +$13.5K 0.01% 415
2025
Q2 		$26.8K Buy
6,667
+35
+0.5% +$115 ﹤0.01% 442
2025
Q1 		$23K Sell
6,632
-379
-5% -$1.68K ﹤0.01% 454
2024
Q4 		$46.1K Buy
+7,011
New +$55.2K ﹤0.01% 453

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

China Universal Asset Management Company's LXEO Position: Q1 2026 in Review

China Universal Asset Management Company increased its Lexeo Therapeutics (LXEO) stake by 8.9% in Q1 2026, buying an estimated $7.5K and bringing the position to 12,952 shares worth $74.3K. The position accounts for 0.01% of the portfolio, ranked #432.

China Universal Asset Management Company first reported a position in LXEO in Q4 2024 and has held it in 6 quarters since. The position peaked at $118K in Q4 2025. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • China Universal Asset Management Company held 12,952 shares of Lexeo Therapeutics worth $74.3K as of Q1 2026.
  • China Universal Asset Management Company bought 1,059 Lexeo Therapeutics shares in Q1 2026, an estimated $7.5K.
  • Lexeo Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #432 holding.
  • China Universal Asset Management Company first reported a position in Lexeo Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • China Universal Asset Management Company's Lexeo Therapeutics position peaked at $118K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.